Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+266.4%
5Y CAGR+185.9%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+266.4%/yr
vs +455.9%/yr prior
5Y CAGR
+185.9%/yr
Recent acceleration
Acceleration
-189.5pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
190.9x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $46.97M | +266.2% |
| 2024 | $12.83M | +705.1% |
| 2023 | $1.59M | +66.8% |
| 2022 | $955000.00 | -54.0% |
| 2021 | $2.08M | +743.5% |
| 2020 | $246000.00 | +232.4% |
| 2019 | $74000.00 | +7300.0% |
| 2018 | $1000.00 | - |